Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@Tickeron 10
@newsfilterio 8
@Biotech2050 5
@TranscriptDaily 5
@Gambiste1 4

Recent Tweets for XLRN

YuZhu4 @YuZhu4
RT @semodough: Piper $XLRN like the risk/reward set-up for PoC data with sotatercept in PAH which are expected in 1Q20. Regardless of tsota…
4:01pm
Tickeron @Tickeron
$XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/6oDjPEYgKH
12:01pm
Gambiste1 @Gambiste1
RT @IlliniJJ: $XLRN Topline results from the PULSAR Phase 2 trial in patients with PAH are expected in the first quarter of 2020. In prec…
12:01pm
semodough @semodough
Piper $XLRN like the risk/reward set-up for PoC data with sotatercept in PAH which are expected in 1Q20. Regardless… https://t.co/QnQsDcaZP6
12:01pm
IlliniJJ @IlliniJJ
$XLRN Topline results from the PULSAR Phase 2 trial in patients with PAH are expected in the first quarter of 2020… https://t.co/PlpANU4fJw
12:01pm
TickerReport @TickerReport
ValuEngine Lowers Acceleron Pharma $XLRN to Hold https://t.co/eMcJHRhdpd
6:01am
bbnsnews @bbnsnews
ValuEngine Lowers Acceleron Pharma $XLRN to Hold https://t.co/bW86bTlyE1
6:01am
EnterpriseLeade @EnterpriseLeade
Zacks Investment Research Lowers Acceleron Pharma $XLRN to Sell https://t.co/YFpEd1WbUu
6:01am
Tickeron @Tickeron
$XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/jajINpGqdZ
January 19th 2020, 12:01pm
TranscriptDaily @TranscriptDaily
Analysts Set Acceleron Pharma Inc $XLRN Target Price at $59.10 https://t.co/PlOca2dCN3
January 19th 2020, 11:01am
ConsumerFeed @ConsumerFeed
Acceleron Pharma $XLRN Downgraded by ValuEngine https://t.co/kfvyPCJQgY
January 19th 2020, 10:01am
Gambiste1 @Gambiste1
RT @msmoneymoves: Our weekend at @MSMoneyMoves has been full of new coverage for our clinical pipeline score! We just went live with $XLRN…
January 19th 2020, 10:01am
newsfilterio @newsfilterio
Acceleron Pharma Downgraded by ValuEngine to Hold $XLRN https://t.co/XnkuWzV76F
January 18th 2020, 4:01pm
newsfilterio @newsfilterio
Rhenman & Partners Asset Management AB Boosts Stock Position in Acceleron Pharma Inc $XLRN https://t.co/OticSwmO52
January 18th 2020, 12:01pm
YuZhu4 @YuZhu4
RT @semodough: Hcw $XLRN believe drug is safe and effective,expect approval in MDS at least by PDUFA date of April 4, 2020, or perhaps befo…
January 18th 2020, 11:01am
semodough @semodough
Hcw $XLRN believe drug is safe and effective,expect approval in MDS at least by PDUFA date of April 4, 2020, or per… https://t.co/rSWYCmTB2x
January 18th 2020, 9:01am
ZolmaxNews @ZolmaxNews
ValuEngine Downgrades Acceleron Pharma $XLRN to Hold https://t.co/sAeXjdQLdC
January 18th 2020, 1:01am
TranscriptDaily @TranscriptDaily
Acceleron Pharma $XLRN Downgraded by ValuEngine to Hold https://t.co/8HsIDIgFPp
January 17th 2020, 10:01pm
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Downgraded to Sell at Zacks Investment Research https://t.co/5AyTinxEX1
January 17th 2020, 10:01pm
stocknewstimes @stocknewstimes
Acceleron Pharma $XLRN Downgraded by ValuEngine to Hold https://t.co/9AKwOEcyOe
January 17th 2020, 10:01pm
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/GpWXRq3ZOY
January 17th 2020, 9:01pm
Tickeron @Tickeron
$XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/fJBDLwojXr
January 17th 2020, 1:01pm
newsfilterio @newsfilterio
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom.. $XLRN… https://t.co/3UXPc5KDN2
January 17th 2020, 8:01am
newsfilterio @newsfilterio
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom D.. $XLRN… https://t.co/VNsjR1FHch
January 17th 2020, 8:01am
gcassidy718 @gcassidy718
$XLRN Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 3.83 % change recently https://t.co/Cjbv1BHC3y
January 16th 2020, 4:01pm
stocknewstimes @stocknewstimes
Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/VU1BSMAwAS
January 16th 2020, 4:01pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/nWLwF6lUDu
January 16th 2020, 4:01pm
Tickeron @Tickeron
$XLRN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on January 9, 2020. View odds… https://t.co/jeyz8bh0Cn
January 16th 2020, 2:01pm
IlliniJJ @IlliniJJ
$XLRN - another nice move today https://t.co/dl4FjnHDtJ
January 16th 2020, 11:01am
TranscriptDaily @TranscriptDaily
Acceleron Pharma $XLRN Reaches New 1-Year High at $56.90 https://t.co/PEuKigCN6s
January 16th 2020, 10:01am
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/xyE2PLHGd4 #stocks
January 16th 2020, 10:01am
LargeVoidBot @LargeVoidBot
09:51 New 52wk Highs: $XLRN
January 16th 2020, 9:01am
Biotech2050 @Biotech2050
Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes $XLRN $BMY https://t.co/QRm3ZzROwd
January 15th 2020, 11:01pm
SeekingAlpha @SeekingAlpha
$XLRN - Acceleron Pharma (XLRN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow. Subscribe to… https://t.co/zQHJ5zCoUS
January 14th 2020, 2:01pm
BlueBioNow @BlueBioNow
$XLRN What happened??? why the bounce?? -5.59 % change recently https://t.co/gR0MpM5fid
January 13th 2020, 5:01pm
Tickeron @Tickeron
$XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/GhAC7Oj7t4
January 13th 2020, 1:01pm
YuZhu4 @YuZhu4
RT @Biotech2050: $BMY's 2021 opportunities - includes $XLRN's drug #JPM20 https://t.co/ydJ2bywDr8
January 13th 2020, 1:01pm
Biotech2050 @Biotech2050
$BMY's 2021 opportunities - includes $XLRN's drug #JPM20 https://t.co/ydJ2bywDr8
January 13th 2020, 1:01pm
Biotech2050 @Biotech2050
#JPM20 $XLRN $GILD webcasts started at the same time!
January 13th 2020, 12:01pm
ConsumerFeed @ConsumerFeed
Zacks: Analysts Expect Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $32.58 Million https://t.co/yuqcZQl2zm
January 12th 2020, 6:01pm
dispatchtribune @dispatchtribune
$32.58 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/AMGteJPeDr
January 12th 2020, 6:01pm
tradersreport @tradersreport
RT @Tickeron: $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for this and oth…
January 12th 2020, 2:01pm
Tickeron @Tickeron
$XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/QHhpjtt7rQ
January 12th 2020, 2:01pm
Gambiste1 @Gambiste1
RT @AcceleronPharma: Just touched down in #SFO. Check out our presentation tomorrow at 9:30 am PT $XLRN #JPM20
January 12th 2020, 1:01pm
AcceleronPharma @AcceleronPharma
Just touched down in #SFO. Check out our presentation tomorrow at 9:30 am PT $XLRN #JPM20
January 12th 2020, 12:01pm
gcassidy718 @gcassidy718
$XLRN what a Company -5.59 % change recently https://t.co/Cjbv1BHC3y
January 11th 2020, 10:01pm
ThisLincolnian @ThisLincolnian
Acceleron Pharma $XLRN Hits New 52-Week High at $55.37 https://t.co/twqDTMmARg
January 11th 2020, 2:01am
BlueBioNow @BlueBioNow
$XLRN might be worth taking a position when this bottoms -2.35 % change recently https://t.co/gR0MpM5fid
January 10th 2020, 11:01pm
TheMarketsDaily @TheMarketsDaily
$32.58 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/COgtOh75r6
January 10th 2020, 11:01pm
TranscriptDaily @TranscriptDaily
-$0.30 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/uN2AnbpEU6
January 10th 2020, 11:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.